TY - JOUR
T1 - Conceptualising the commercial determinants of suicide
T2 - broadening the lens on suicide and self-harm prevention
AU - van Schalkwyk, May C. I.
AU - Collin, Jeff
AU - Eddleston, Michael
AU - Petticrew, Mark
AU - Pearson, Melissa
AU - Schölin, Lisa
AU - Maani, Nason
AU - Konradsen, Flemming
AU - Gunnell, David
AU - Knipe, Duleeka
N1 - Funding Information:
MCIvS, MPet, and JC have funding through and are co-investigators in the SPECTRUM consortium which is funded by the UK Prevention Research Partnership, a consortium of UK funders (UK research and innovation research councils [Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, and Natural Environment Research Council], charities [British Heart Foundation, Cancer Research UK, the Wellcome Trust, and The Health Foundation], and government [Scottish Government Chief Scientist Office, Health and Care Research Wales, NIHR, and Public Health Agency]). NM (co-investigator) and MPet (principal investigator) have grant funding from the NIHR “Three Schools” Mental Health Programme. MCIvS is funded by the NIHR Doctoral Fellowship (NIHR3000156) and her research is also partially supported by the NIHR Applied Research Collaboration North Thames. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. DK is funded through the Elizabeth Blackwell Institute for Health Research at the University of Bristol, UK, which is supported by the Wellcome Trust. DK is also in receipt of a grant from the CPSP. LS is supported by the CPSP. The CPSP is funded by a grant from Open Philanthropy, at the recommendation of GiveWell, CA, USA.
Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/5
Y1 - 2023/5
N2 - Suicide is preventable, yet, in many settings, robust suicide prevention strategies have not been implemented. Although a commercial determinants of health lens is increasingly being applied to industries important to the field of suicide prevention, the interplay between the vested interests of commercial actors and suicide has received little attention. There is a need to shift attention to the causes of the causes, directing more focus to the ways that commercial determinants influence suicide and shape suicide prevention strategies. Such a shift in perspective, with an evidence base and precedents to draw upon, has transformative potential for research and policy agendas dedicated to understanding and addressing upstream modifiable determinants of suicide and self-harm. We propose a framework intended to help guide efforts to conceptualise, research, and address the commercial determinants of suicide and their inequitable distribution. We hope these ideas and lines of inquiry help to catalyse connections between disciplines and open further debate and discussion as to how to take such an agenda forward.
AB - Suicide is preventable, yet, in many settings, robust suicide prevention strategies have not been implemented. Although a commercial determinants of health lens is increasingly being applied to industries important to the field of suicide prevention, the interplay between the vested interests of commercial actors and suicide has received little attention. There is a need to shift attention to the causes of the causes, directing more focus to the ways that commercial determinants influence suicide and shape suicide prevention strategies. Such a shift in perspective, with an evidence base and precedents to draw upon, has transformative potential for research and policy agendas dedicated to understanding and addressing upstream modifiable determinants of suicide and self-harm. We propose a framework intended to help guide efforts to conceptualise, research, and address the commercial determinants of suicide and their inequitable distribution. We hope these ideas and lines of inquiry help to catalyse connections between disciplines and open further debate and discussion as to how to take such an agenda forward.
UR - http://www.scopus.com/inward/record.url?scp=85152136364&partnerID=8YFLogxK
U2 - 10.1016/S2215-0366(23)00043-3
DO - 10.1016/S2215-0366(23)00043-3
M3 - Review article
C2 - 37019125
AN - SCOPUS:85152136364
SN - 2215-0366
VL - 10
SP - 363
EP - 370
JO - The Lancet Psychiatry
JF - The Lancet Psychiatry
IS - 5
ER -